Results 51 to 60 of about 12,181 (265)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Does agricultural mechanization improve agricultural environmental efficiency?

open access: yesFrontiers in Environmental Science
Improving agricultural environmental efficiency (AEE) is critical for sustainable and green agricultural advancement. However, there is limited research on the impact of agricultural mechanization on agricultural environmental efficiency.
Fuzhen Yan   +4 more
doaj   +1 more source

Survey of US Passionfruit Growers’ Production Practices and Support Needs

open access: yesHortTechnology, 2023
Passionfruits (Passiflora sp.) are widely grown throughout tropical regions of the world. Burgeoning new interest in this fruit in both its fresh and processed forms has led to an increase in planting outside of traditional growing zones.
Eric T. Stafne   +13 more
doaj   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Farmer typology and drivers of agricultural mechanization use in Haiti

open access: yesScientific Reports
Agricultural mechanization is recognized as an important technology to increase agricultural productivity, face labor shortages, and reduce post-harvest loss.
Bénédique Paul, Jude Régis
doaj   +1 more source

Ingineering and technological problems of improving the environmental safety of crop production [PDF]

open access: yesBIO Web of Conferences
The article deals with engineering and technological problems of improving the environmental safety of crop production as a complex biotechnical system, for the environment, consumers of crop production and machine operators who ensure production in the ...
Shirokov Yuri, Tihnenko Valerij
doaj   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy